5 Star
.
Now, Punjabi singer Gippy Grewal 'receives' extortion call

Now, Punjabi singer Gippy Grewal 'receives' extortion call

02 Jun 2018 | 1:16 PM
.
.
.
.
.

Burn Pits 360 maintains its own burn pit registry on their website, completely separate from the official Airborne Hazards and Open Burn Pits Registry maintained by the Department of Veterans Affairs. The main difference between the two registries is that Burn Pits 360 offers a way for family members to update the system to track diagnosed with cancer or in the event of their veteran’s death. Nearly 8,000 veterans have signed up for the Burn Pits 360 registry. Exposed veterans still need to sign up for the VA registry, however.

.
With this year's terrible flu season a fresh memory, a new study finds that more U.S. hospitals are requiring staffers to get flu shots, but VA hospitals lag behind.
.
http://game-rapidshare.com/Rigano-grandma-of-Bollbach-from-Vallda?Stillsist=137
Incorrect email format

By signing up you agree to receive email newsletters and notifications from MIT Technology Review. You can unsubscribe at any time. View our Privacy Policy for more details.

“These children shouldn’t have to live out life in a wheelchair when they could run, walk, and play,” says Davis, a founder of the Texas SMA Newborn Screening Coalition.

Time is of the essence in treating SMA type 1. A single mutation in the SMN1 gene causes swift and irreversible damage to a baby’s motor neurons, which are located in the brain stem and spinal cord. This damage leads to muscle weakness, and children eventually develop trouble swallowing and breathing.

Davis’s son, Hunter, who is now six years old, had already lost all movement at two weeks of age. Hunter is alive thanks to Spinraza, a breakthrough SMA drug approved in December 2016. Children who have received the drug have made remarkable recoveries. But it must be given through a spinal tap once every four months, for life. It costs a whopping 0,000 for the first year of treatment and 5,000 every year after that.

. .
.
.
.
. .